- Fund Type: Fund of Funds
- Objective: Flexible Portfolio
- Asset Class: Asset Allocation
- Geographic Focus: Canada
OceanRock Growth & Income Portfolio
+ Add to WatchlistORCKGRIA:CN
10.66 CAD 0.03 0.32%As of 07:59:30 ET on 05/22/2013.
Snapshot for OceanRock Growth & Income Portfolio (ORCKGRIA)
| Year To Date: | +5.94% | 3-Month: | +2.85% | 3-Year: | - | 52-Week Range: | 9.40 - 10.70 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +3.35% | 1-Year: | +12.48% | 5-Year: | - | Beta vs SPTSX: | 0.61 |
Fund Profile & Information for ORCKGRIA
OceanRock Growth & Income Portfolio is an open-end fund incorporated in Canada. The Fund's objective is to achieve long-term capital growth along with preservation of capital while providing for current income by investing primarily in a combination of OceanRock Funds. The Fund invests in equities, cash equivalents and fixed income.
| Inception Date: | 01-27-2005 | Telephone: | 1-866-924-6767 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | - | ||
Fundamentals for ORCKGRIA
| NAV | (on 2013-05-22) 10.66 |
|---|---|
| Assets (M) | (on 2013-03-28) 170,011.34 |
| Fund Leveraged | N |
| Minimum Investment | 250.00 |
| Minimum Subsequent Investment | 50.00 |
Dividends for ORCKGRIA
No dividends reported
Fees & Expenses for ORCKGRIA
| Front Load | - |
|---|---|
| Back Load | 6.00 |
| Current Mgmt Fee | - |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | 2.66 |
Top Fund Holdings for ORCKGRIA
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| OceanRock Canadian Equity Fund | 252,969 | 2,589,516 | 34.576% |
| Meritas Canadian Bond Fund | 208,693 | 2,462,683 | 32.882% |
| OceanRock International Equity | 104,723 | 1,125,469 | 15.028% |
| OceanRock International Equity | 98,951 | 1,114,132 | 14.876% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page